Latest News

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

Presentation

Asa and other industry leaders interviewed

Asa Waldstein's content is mentioned in this newsletter.

This edition talks about labeling essentials and best practices.

Asa Waldstein quoted

Asa Waldstein and two top advertising attorneys share their tips and best practices for marketing stress supplements.
🔷Stress-free rules Ivan Wasserman, Amin Talati Wasserman, LLP
🔷Pooja's do's and don'ts Pooja Nair
🔷Asa's helpful hints Supplement Advisory Group

Asa Waldstein, Principal, Supplement Advisory Group, discussed the most recent info on FDA and FTC’s thinking regarding immune support in Communicating in-store and online—where are we now? “FDA is going back many years and citing multi-year-old social media posts in warning letters,” he shared. “One cited a social media post from 2014, and they treat those the same way as new posts. Hashtags are also claims. ‘Liking’ a post is a claim. Replying to or reposting a customer comment on social media, that’s a claim. All marketing is considered ‘labeling’.” That includes, he said, product reviews and testimonials; infographics; citing studies; blogs; and more.

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

This edition talks about manufacturing essentials and reasons to think twice when building an overly robust Quality Management System (QMS).

Asa and other industry leaders interviewed

Asa writes the FDA and Hemp section of this prestigious annual paid publication.

Asa and other industry leaders interviewed

Asa and other industry leaders interviewed

Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/

Asa and other industry leaders interviewed.

Asa and other industry leaders interviewed in the New Hope article.

The developing state and federal regulatory situation for ingestible CBD and hemp have made marketing these products a bit tricky.

Asa and other industry leaders interviewed

Asa Waldstein & other leaders interviewed